CTRI/2012/07/002790已完成未知
Double Blind Randomised placebo controlled trial to evaluate intravenous clonidine as a hypotensive agent in Functional Endoscopic Sinus surgery
Christian Medical College Fluid Research Fund0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ASA 1 and 2
排除标准
- •1. Hypertension
- •2. Diabetes with autonomic neuropathy
- •3. Treatment with clonidine, beta blocker or calcium channel blocker
- •4. Pregnant mothers
- •5. Age <18 and >65 years
研究者
相似试验
招募中
2 期
Homeopathic medicines for anaemiaCTRI/2022/03/041072The Calcutta Homoeopathic Medical College and Hospital
已完成
不适用
Randomised Double Blinded Placebo Controlled Trial of Magnesium Sulphate in Reducing Length of Hospital Stay In Patients Undergoing Elective Large Bowel ResectioISRCTN72173144Ipswich Hospital NHS Trust (UK)108
进行中（未招募）
不适用
Randomized placebo-controlled double-blind trial to assess safety and efficacy of erythropoietin in adult patients with Friedreich's ataxia (a pilot study) - NDFriedreich ataxia (FRDA) is a rare autosomal recessive neurodegenerative disorder caused a mutation in the FXN gene, which encodes a protein named frataxin. As a result of the mutation, frataxin is quantitatively reduced but qualitatively normal. Thus, any pharmacological agent able to increase frataxin intracellular levels would have a great therapeutic relevance.MedDRA version: 6.1Level: PTClassification code 10003591EUCTR2007-003357-85-ITISTITUTO NEUROLOGICO CARLO BESTA
已完成
3 期
ONTRAC: Effect of oral nicotinamide (vitamin B3) on incidence of nonmelanoma skin cancer and actinic keratoses: a randomised controlled trial (Oral Nicotinamide To Reduce Actinic Cancer)Basal cell carcinomaACTRN12612000625875niversity of Sydney386
已完成
2 期
Effect of oral nicotinamide (vitamin B3) on nonmelanoma skin cancer incidence and actinic keratoses in renal transplant recipients: a randomised controlled trialBasal cell carcinomaACTRN12612000628842niversity of Sydney80